Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer

Background: Previously we identified a DNA damage response–deficient (DDRD) molecular subtype within breast cancer. A 44-gene assay identifying this subtype was validated as predicting benefit from DNA-damaging chemotherapy. This subtype was defined by interferon signaling. In this study, we address...

Descripción completa

Detalles Bibliográficos
Autores principales: Parkes, Eileen E., Walker, Steven M., Taggart, Laura E., McCabe, Nuala, Knight, Laura A., Wilkinson, Richard, McCloskey, Karen D., Buckley, Niamh E., Savage, Kienan I., Salto-Tellez, Manuel, McQuaid, Stephen, Harte, Mary T., Mullan, Paul B., Harkin, D. Paul, Kennedy, Richard D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441301/
https://www.ncbi.nlm.nih.gov/pubmed/27707838
http://dx.doi.org/10.1093/jnci/djw199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441301/
https://www.ncbi.nlm.nih.gov/pubmed/27707838
http://dx.doi.org/10.1093/jnci/djw199

Ejemplares similares